S&P 500   3,166.41 (-0.07%)
DOW   28,110.79 (-0.08%)
QQQ   207.04 (+0.26%)
AAPL   274.11 (+0.98%)
FB   194.43 (-1.18%)
MSFT   154.55 (+0.85%)
GOOGL   1,345.61 (-0.21%)
AMZN   1,763.88 (+0.20%)
CGC   21.60 (+2.18%)
NVDA   224.07 (+0.00%)
MU   51.32 (+0.69%)
BABA   204.74 (+0.12%)
T   38.04 (-0.83%)
AMD   41.66 (-2.18%)
ACB   2.66 (+2.31%)
F   9.21 (-1.29%)
NFLX   298.80 (+0.12%)
BAC   34.50 (-0.55%)
GILD   65.99 (-2.43%)
S&P 500   3,166.41 (-0.07%)
DOW   28,110.79 (-0.08%)
QQQ   207.04 (+0.26%)
AAPL   274.11 (+0.98%)
FB   194.43 (-1.18%)
MSFT   154.55 (+0.85%)
GOOGL   1,345.61 (-0.21%)
AMZN   1,763.88 (+0.20%)
CGC   21.60 (+2.18%)
NVDA   224.07 (+0.00%)
MU   51.32 (+0.69%)
BABA   204.74 (+0.12%)
T   38.04 (-0.83%)
AMD   41.66 (-2.18%)
ACB   2.66 (+2.31%)
F   9.21 (-1.29%)
NFLX   298.80 (+0.12%)
BAC   34.50 (-0.55%)
GILD   65.99 (-2.43%)
S&P 500   3,166.41 (-0.07%)
DOW   28,110.79 (-0.08%)
QQQ   207.04 (+0.26%)
AAPL   274.11 (+0.98%)
FB   194.43 (-1.18%)
MSFT   154.55 (+0.85%)
GOOGL   1,345.61 (-0.21%)
AMZN   1,763.88 (+0.20%)
CGC   21.60 (+2.18%)
NVDA   224.07 (+0.00%)
MU   51.32 (+0.69%)
BABA   204.74 (+0.12%)
T   38.04 (-0.83%)
AMD   41.66 (-2.18%)
ACB   2.66 (+2.31%)
F   9.21 (-1.29%)
NFLX   298.80 (+0.12%)
BAC   34.50 (-0.55%)
GILD   65.99 (-2.43%)
S&P 500   3,166.41 (-0.07%)
DOW   28,110.79 (-0.08%)
QQQ   207.04 (+0.26%)
AAPL   274.11 (+0.98%)
FB   194.43 (-1.18%)
MSFT   154.55 (+0.85%)
GOOGL   1,345.61 (-0.21%)
AMZN   1,763.88 (+0.20%)
CGC   21.60 (+2.18%)
NVDA   224.07 (+0.00%)
MU   51.32 (+0.69%)
BABA   204.74 (+0.12%)
T   38.04 (-0.83%)
AMD   41.66 (-2.18%)
ACB   2.66 (+2.31%)
F   9.21 (-1.29%)
NFLX   298.80 (+0.12%)
BAC   34.50 (-0.55%)
GILD   65.99 (-2.43%)
Log in

NASDAQ:SNOA - Sonoma Pharmaceuticals Stock Price, Forecast & News

$4.39
-0.01 (-0.23 %)
(As of 12/13/2019 12:06 PM ET)
Today's Range
$4.25
Now: $4.39
$4.40
50-Day Range
$3.94
MA: $5.14
$6.69
52-Week Range
$3.33
Now: $4.39
$10.35
Volume5,006 shs
Average Volume31,298 shs
Market Capitalization$5.84 million
P/E RatioN/A
Dividend YieldN/A
Beta0.89
Sonoma Pharmaceuticals, Inc, a specialty pharmaceutical company, develops and markets solutions for the treatment of chronic skin conditions and advanced tissue care in the United States and internationally. The company offers Levicyn, a hypochlorous acid (HOCl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; SebuDerm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and Ceramax, a Lipogrid based skin barrier cream indicated to relieve and manage the burning and itching associated with various skin conditions. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SNOA
CUSIPN/A
Phone707-283-0550

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.97 million
Book Value$7.89 per share

Profitability

Net Income$-11,800,000.00

Miscellaneous

Employees78
Market Cap$5.84 million
Next Earnings Date2/13/2020 (Estimated)
OptionableNot Optionable

Receive SNOA News and Ratings via Email

Sign-up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter.


Sonoma Pharmaceuticals (NASDAQ:SNOA) Frequently Asked Questions

What is Sonoma Pharmaceuticals' stock symbol?

Sonoma Pharmaceuticals trades on the NASDAQ under the ticker symbol "SNOA."

How were Sonoma Pharmaceuticals' earnings last quarter?

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) posted its quarterly earnings results on Thursday, November, 14th. The company reported ($0.91) earnings per share for the quarter, beating analysts' consensus estimates of ($1.18) by $0.27. The company had revenue of $4.97 million for the quarter. Sonoma Pharmaceuticals had a negative net margin of 31.06% and a negative return on equity of 52.70%. View Sonoma Pharmaceuticals' Earnings History.

When is Sonoma Pharmaceuticals' next earnings date?

Sonoma Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Sonoma Pharmaceuticals.

Has Sonoma Pharmaceuticals been receiving favorable news coverage?

News headlines about SNOA stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Sonoma Pharmaceuticals earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Sonoma Pharmaceuticals.

Are investors shorting Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals saw a increase in short interest during the month of November. As of November 29th, there was short interest totalling 24,800 shares, an increase of 119.5% from the November 14th total of 11,300 shares. Based on an average trading volume of 11,800 shares, the short-interest ratio is presently 2.1 days. Currently, 2.0% of the company's stock are sold short. View Sonoma Pharmaceuticals' Current Options Chain.

Who are some of Sonoma Pharmaceuticals' key competitors?

What other stocks do shareholders of Sonoma Pharmaceuticals own?

Who are Sonoma Pharmaceuticals' key executives?

Sonoma Pharmaceuticals' management team includes the folowing people:
  • Mr. Frederick J. Sandford, CEO, Interim CFO & Director (Age 58)
  • Mr. Marc Umscheid, Chief Operating Officer (Age 50)
  • Dr. Robert Northey, Exec. VP of R&D (Age 62)
  • Mr. Bruce Thornton, Exec. VP of International Operations & Sales (Age 55)
  • Ms. Victoria Covel, Assistant Controller

How do I buy shares of Sonoma Pharmaceuticals?

Shares of SNOA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Sonoma Pharmaceuticals' stock price today?

One share of SNOA stock can currently be purchased for approximately $4.39.

How big of a company is Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals has a market capitalization of $5.84 million and generates $18.97 million in revenue each year. Sonoma Pharmaceuticals employs 78 workers across the globe.View Additional Information About Sonoma Pharmaceuticals.

What is Sonoma Pharmaceuticals' official website?

The official website for Sonoma Pharmaceuticals is http://www.sonomapharma.com/.

How can I contact Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals' mailing address is 1129 NORTH MCDOWELL BLVD., PETALUMA CA, 94954. The company can be reached via phone at 707-283-0550 or via email at [email protected]


MarketBeat Community Rating for Sonoma Pharmaceuticals (NASDAQ SNOA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  203 (Vote Outperform)
Underperform Votes:  195 (Vote Underperform)
Total Votes:  398
MarketBeat's community ratings are surveys of what our community members think about Sonoma Pharmaceuticals and other stocks. Vote "Outperform" if you believe SNOA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNOA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel